Hong Kong, China

Runming Wang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Runming Wang

Introduction

Runming Wang is a distinguished inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and methods for treating bacterial infections and cancer. With a total of 4 patents to his name, Wang's work is recognized for its potential impact on medical treatments.

Latest Patents

Wang's latest patents include innovative pharmaceutical compositions that utilize silver and gold compounds. One of his notable inventions involves a combination of polymyxin antibiotics and mobile colistin resistant proteins (MCRs) inhibitors. This invention aims to address MCR-producing bacterial infections through multiple mechanisms. Another significant patent focuses on the use of bismuth(III) complexes as adjuvants in platinum-based chemotherapy. This method seeks to reduce the organ toxicity associated with cisplatin while maintaining its anticancer efficacy.

Career Highlights

Runming Wang is affiliated with The University of Hong Kong, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing critical health challenges. Wang's contributions are paving the way for advancements in pharmaceutical treatments.

Collaborations

Wang collaborates with esteemed colleagues, including Hongzhe Sun and Hongyan Li. These partnerships enhance the research efforts and broaden the scope of their innovative projects.

Conclusion

Runming Wang's inventive spirit and dedication to pharmaceutical research are evident in his patents and collaborations. His work continues to inspire advancements in medical treatments, showcasing the importance of innovation in addressing global health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…